Michael S. Weiss - 05 Jul 2023 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Reporting relationship: Director
Issuer ticker: MBIO
Reported as of: 05 Jul 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2023, 16:06:36 UTC
Prior SEC filing: 15 Jun 2023
Next SEC filing: 14 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Matthew Wein, Attorney-in-Fact

Key filing fact

Michael S. Weiss filed Form 4 for MUSTANG BIO, INC. (MBIO) on 07 Jul 2023.

Key facts

This page summarizes Michael S. Weiss's Form 4 filing for MUSTANG BIO, INC. (MBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2023, 16:06.

Change

Previous filing in this sequence was filed on 15 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MBIO transaction

COMMON STOCK, PAR VALUE $0.0001

Award

Transaction value: $0
Shares: +7,246
Change %: +17%
Price: $0.000000
Shares after: 49,637
Date: 05 Jul 2023
Ownership: See Footnote
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date.

Footnote F2

Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.

Footnote F3

Includes restricted share units, which vest over various time periods.

Footnote F4

The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.